Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer
Authors
Keywords
Epigenetics, DNA methylation, Genetic alterations, Gastric cancer, Cancer-related pathway
Journal
Gastric Cancer
Volume 18, Issue 1, Pages 65-76
Publisher
Springer Nature
Online
2014-02-08
DOI
10.1007/s10120-014-0348-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gene methylation in gastric cancer
- (2013) Yiping Qu et al. CLINICA CHIMICA ACTA
- Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients
- (2013) Su Jin Lee et al. INVESTIGATIONAL NEW DRUGS
- An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
- (2013) D. Rohle et al. SCIENCE
- A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data
- (2012) Andrew E. Teschendorff et al. BIOINFORMATICS
- Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum
- (2012) D H Yoon et al. BRITISH JOURNAL OF CANCER
- Development of a novel approach, the epigenome-based outlier approach, to identify tumor-suppressor genes silenced by aberrant DNA methylation
- (2012) Mizuho Kikuyama et al. CANCER LETTERS
- Comprehensive DNA methylation and extensive mutation analyses reveal an association between the CpG island methylator phenotype and oncogenic mutations in gastric cancers
- (2012) Jeong Goo Kim et al. CANCER LETTERS
- Clinical Integration of Next-Generation Sequencing Technology
- (2012) R.R. Gullapalli et al. CLINICS IN LABORATORY MEDICINE
- The BOLERO-2 trial: the addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer
- (2012) Julia A Beaver et al. Future Oncology
- Trials with ‘epigenetic’ drugs: An update
- (2012) Angela Nebbioso et al. Molecular Oncology
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
- (2011) Mark A. Dawson et al. NATURE
- Targeting the epigenome for treatment of cancer
- (2011) E-J Geutjes et al. ONCOGENE
- Evaluation of the Infinium Methylation 450K technology
- (2011) Sarah Dedeurwaerder et al. Epigenomics
- Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer
- (2011) R. A. Juergens et al. Cancer Discovery
- Phase 3 trial of everolimus for metastatic renal cell carcinoma
- (2010) Robert J. Motzer et al. CANCER
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Development of a Novel Output Value for Quantitative Assessment in Methylated DNA Immunoprecipitation-CpG Island Microarray Analysis
- (2009) S. Yamashita et al. DNA RESEARCH
- The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands
- (2009) H. Takeshima et al. GENOME RESEARCH
- Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells
- (2009) Madeleine P Ball et al. NATURE BIOTECHNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started